Cervical Cancer with Radiotherapy Treatment

Novita Ariani; Muhammad Azhari Herli; Nurul Laila

Novita Ariani Fakultas Kedokteran, Universitas Andalas
Muhammad Azhari Herli Prodi Farmasi, Fakultas MIPA dan Kesehatan, Universitas Muhammadiyah Riau
Nurul Laila Fakultas Kesehatan Masyarakat, Universitas Andalas

Keywords: Cervical Cancer, Treatment, Radiotherapy

Abstract

Cervical cancer is an abnormal growth of cells in the cervix, which its etiological agent is infected by the human papillomavirus. Globally, cervical cancer is the fourth most common cancer in women, one of the most frequently diagnosed cancer, and a cause of cancer-related death. The Global Cancer Statistics 2022, censused approximately 660,000 new cases and 350,000 deaths worldwide. Therefore, to contrast cervical cancer as a public health problem, the World Health Organization in 2020, conducted a global health strategy with tertiary interventions: (1) prevention through HPV vaccination; (2) screening and precancerous lesions treatment; and (3) adequate treatment of invasive cervical. Currently, there are three therapeutic modalities which are surgery, chemotherapy, and radiotherapy. These may include one or a combination of surgery, chemotherapy and radiotherapy. Radiotherapy is a major treatment in the management of cervical cancer, which uses high energy x-rays.

Downloads

Download data is not yet available.

References

G. Caruso et al., “Cervical cancer: a new era,” Int J Gynecol Cancer, p. ijgc–2024–005579, Aug. 2024, doi: 10.1136/ijgc-2024-005579.

P. Ferrara, G. Dallagiacoma, F. Alberti, L. Gentile, P. Bertuccio, and A. Odone, “Prevention, diagnosis and treatment of cervical cancer: A systematic review of the impact of COVID-19 on patient care,” Preventive Medicine, vol. 164, p. 107264, Nov. 2022, doi: 10.1016/j.ypmed.2022.107264.

T. W. H. O. WHO, “Global Cancer Observatory 2022 - Cervix Uteri.”

C. A. Burmeister et al., “Cervical cancer therapies: Current challenges and future perspectives,” Tumour Virus Research, vol. 13, p. 200238, Jun. 2022, doi: 10.1016/j.tvr.2022.200238.

R. Kunkule, R. Pakale, and S. Jadhav, “Review on Cervical Cancer,” SDNCRES’s Mahalaxmi Institute of Pharmacy, vol. 2, no. 2, pp. 39–44, 2020.

S. L. Bedell, L. S. Goldstein, A. R. Goldstein, and A. T. Goldstein, “Cervical Cancer Screening: Past, Present, and Future,” Sexual Medicine Reviews, vol. 8, no. 1, pp. 28–37, Jan. 2020, doi: 10.1016/j.sxmr.2019.09.005.

T. Šarenac and M. Mikov, “Cervical Cancer, Different Treatments and Importance of Bile Acids as Therapeutic Agents in This Disease,” Front. Pharmacol., vol. 10, p. 484, Jun. 2019, doi: 10.3389/fphar.2019.00484.

aboutbrachytherapy, “Brachytherapy: The Precise Answer For Tackling Cervical Cancer.” www.aboutbrachytherapy.com, 2021.

W. Prendiville and R. Sankaranarayanan, Colposcopy and treatment of cervical precancer. in IARC technical publication, no. no. 45. Lyon, France: International Agency for Research on Cancer, World Health Organization, 2017.